HR 919 ยท Chronic Disease Flexible Coverage Act
Received in the Senate and Read twice and referred to the Committee on Finance.
- Introduced
- Feb 4, 2025
- Latest action
- Mar 5, 2025
- Sponsor
- Rep. Vern Buchanan [R-FL-16]
- Policy area
- Taxation
- Cosponsors
- 2
Summary
Chronic Disease Flexible Coverage Act This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold. Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease; anti-resorptive therapy for individuals with osteoporosis or osteopenia; beta-blockers for individuals with congestive heart failure or coronary artery disease; blood pressure monitors for individuals with hypertension; inhaled corticosteroids and peak flow meters for individuals with asthma; insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes; international normalized ratio testing for individuals with liver disease or bleeding disorders; low-density lipoprotein testing for individuals with heart disease; statins for individuals with heart disease or diabetes; and selective serotonin reuptake inhibitors for individuals with depression. The bill provides statutory authority for the IRS's guidance.
Recent actions
- Mar 5, 2025 Received in the Senate and Read twice and referred to the Committee on Finance.
- Mar 4, 2025 Motion to reconsider laid on the table Agreed to without objection.
- Mar 4, 2025 On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
- Mar 4, 2025 Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
- Mar 4, 2025 DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
- Mar 4, 2025 Considered under suspension of the rules. (consideration: CR H964-966)
- Mar 4, 2025 Mr. Smith (MO) moved to suspend the rules and pass the bill.
- Feb 4, 2025 Referred to the House Committee on Ways and Means.
Votes
No recorded votes are available for this bill.